Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE)
- PMID: 39337977
- PMCID: PMC11433282
- DOI: 10.3390/life14091195
Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE)
Abstract
This study aims to develop and apply multistate models to estimate, forecast, and manage hospital length of stay during the COVID-19 epidemic without using any external packages. Data from Bellvitge University Hospital in Barcelona, Spain, were analyzed, involving 2285 hospitalized COVID-19 patients with moderate to severe conditions. The implemented multistate model includes transition probabilities and risk rates calculated from transitions between defined states, such as admission, ICU transfer, discharge, and death. In addition to examining key factors like age and gender, diabetes, lymphocyte count, comorbidity burden, symptom duration, and different COVID-19 waves were analyzed. Based on the model, patients hospitalized stay an average of 11.90 days before discharge, 2.84 days before moving to the ICU, or 34.21 days before death. ICU patients remain for about 24.08 days, with subsequent stays of 124.30 days before discharge and 35.44 days before death. These results highlight hospital stays' varying durations and trajectories, providing critical insights into patient flow and healthcare resource utilization. Additionally, it can predict ICU peak loads for specific subgroups, aiding in preparedness. Future work will integrate the developed code into the hospital's Health Information System (HIS) following ISO 13606 EHR standards and implement recursive methods to enhance the model's efficiency and accuracy.
Keywords: COVID-19; comorbidity; diabetes mellitus; hospital length of stay; lymphocytes; mortality; multistate model; prognosis; risk factors.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
References
-
- World Health Organization [(accessed on 17 September 2024)]. Available online: https://www.emro.who.int/health-topics/infectious-diseases/index.html.
-
- Dangerfield C., Fenichel E.P., Finnoff D., Hanley N., Hargreaves Heap S., Shogren J.F., Toxvaerd F. Challenges of integrating economics into epidemiological analysis of and policy responses to emerging infectious diseases. Epidemics. 2022;39:100585. doi: 10.1016/j.epidem.2022.100585. - DOI - PMC - PubMed
-
- WHO COVID-19 Dashboard. [(accessed on 1 January 2024)]. Available online: https://data.who.int/dashboards/covid19/cases?n=c.
-
- Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R. StatPearls. StatPearls Publishing LLC; Treasure Island, FL, USA: 2023. Features, Evaluation, and Treatment of Coronavirus (COVID-19) - PubMed
LinkOut - more resources
Full Text Sources
